Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2006 | 09-2005 | 09-2004 | 09-2003 | 09-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,728 | -6,905 | -17,167 | -2,976 | -11,302 |
| Depreciation Amortization | N/A | 9 | 25 | 160 | 381 |
| Accounts receivable | 13 | 124 | -131 | -64 | 854 |
| Other Working Capital | -345 | -386 | 651 | -1,384 | 729 |
| Other Operating Activity | 1,193 | 316 | 7,981 | -338 | 780 |
| Operating Cash Flow | $-4,867 | $-6,842 | $-8,641 | $-4,602 | $-8,558 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 25 | N/A | 25 | -260 |
| Net Acquisitions | N/A | N/A | N/A | 3,422 | N/A |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -2,013 |
| Other Investing Activity | 315 | 0 | 0 | 0 | 140 |
| Investing Cash Flow | $315 | $25 | $N/A | $3,447 | $-2,133 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 6,000 | 2,020 | 2,578 |
| Debt Repayment | N/A | N/A | N/A | -49 | -25 |
| Common Stock Issued | 5,083 | 62 | 9,436 | 2 | 38 |
| Other Financing Activity | 2,167 | 0 | 0 | -441 | 2,856 |
| Financing Cash Flow | $7,250 | $62 | $15,436 | $1,532 | $5,447 |
| Beginning Cash Position | 626 | 7,381 | 586 | 209 | 5,453 |
| End Cash Position | 3,324 | 626 | 7,381 | 586 | 209 |
| Net Cash Flow | $2,698 | $-6,755 | $6,795 | $377 | $-5,244 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,867 | -6,842 | -8,641 | -4,602 | -8,558 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -260 |
| Free Cash Flow | -4,867 | -6,842 | -8,641 | -4,602 | -8,818 |